All lobbying filings

Infusion Providers Alliance

Infusion Providers Alliance filed a Q2 report for Infusion Providers Alliance on July 18, 2025.

Lobbying for Infusion Providers Alliance

As filed: INFUSION PROVIDERS ALLIANCE for INFUSION PROVIDERS ALLIANCE.

All filings by Infusion Providers Alliance · Everything Infusion Providers Alliance has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 18, 2025

Expenses

$100,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to physician reimbursement for Part B drugs. Issues related to virtual supervision of infusion drugs. H.R. 879 Medicare Patient Access and Practice Stabilization Act Issues related to physician reimbursement to complex drug administration. Issues related to appropriate reimbursement for administration of Part B drugs. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act

Health Issues

Advocating for access to and reimbursement for biosimilars. Issues related to patient access to infusion products for asthma and allergies.

Bills named in this filing 2

H.R. 879
Medicare Patient Access and Practice Stabilization Act of 2025
H.R. 4299
Protecting Patient Access to Cancer and Complex Therapies Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.